Circulating LEAP2 in women with polycystic ovary syndrome: a cross-sectional study of androgenic phenotypes and metabolic correlates
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background Liver-expressed antimicrobial peptide 2 (LEAP2) is an endogenous ghrelin-receptor antagonist implicated in metabolic regulation. Evidence in polycystic ovary syndrome (PCOS) is limited. We evaluated circulating LEAP2 according to PCOS status and phenotype and examined its metabolic and hormonal correlates. Methods This single-center, cross-sectional study with prospective recruitment included 64 women with PCOS and 24 controls without PCOS. Fasting serum LEAP2 was measured by enzyme-linked immunosorbent assay. Multivariable linear regression of log-transformed LEAP2 was adjusted for body mass index (BMI) and homeostasis model assessment of insulin resistance (HOMA-IR). Within PCOS, Spearman correlations were evaluated with false discovery rate correction. Results Median LEAP2 was higher in women with PCOS than in controls (0.493 [0.287–0.863] vs. 0.333 [0.227–0.439] ng/mL; p=0.027). After adjustment for BMI and HOMA-IR, PCOS was associated with a 60.5% higher LEAP2 concentration (ratio of geometric means, 1.605; 95% CI, 1.221–2.109; p=0.001). Adjusted LEAP2 was higher in both hyperandrogenic and non-hyperandrogenic PCOS than in controls. No statistically significant differences were detected across PCOS phenotypes, although substantial differences could not be excluded. Triglycerides were the only correlate remaining significant after false discovery rate correction (Spearman ρ=0.372; q=0.040). In a post hoc adjusted model, each triglyceride doubling was associated with a 52.9% higher LEAP2 concentration (ratio of geometric means, 1.529; 95% CI, 1.256–1.862; p<0.001). Conclusion Circulating LEAP2 is elevated in PCOS after adjustment for BMI and HOMA-IR. No significant phenotype differences were detected, although larger studies are needed. Its association with triglycerides suggests a potential link with altered lipid-related metabolic signaling.
Source: Frontiers in Endocrinology
Authors: Alican Bozdaş(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Validation, Visualization, Writing – original draft, Writing – review & editing), Özge Özbaykal(Data curation, Formal analysis, Resources, Writing – original draft), Zeynep Bağlan Atalay(Data curation, Formal analysis, Methodology, Project administration, Resources, Writing – review & editing), Sevde Nur Fırat(Data curation, Investigation, Project administration, Writing – original draft), Mehmet Şeneş(Formal analysis, Investigation, Methodology, Resources, Validation, Visualization, Writing – review & editing), Işılay Taşkaldıran(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing)
Institution: Ankara Eğitim ve Araştırma Hastanesi
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236816109
